Zucman-Rossi J - Search Results

1

Molecular profiling of liver tumors: classification and clinical translation for decision making.

Pinyol R, Nault JC, Quetglas IM, Zucman-Rossi J, Llovet JM. Pinyol R, et al. Semin Liver Dis. 2014 Nov;34(4):363-75. doi: 10.1055/s-0034-1394137. Epub 2014 Nov 4. Semin Liver Dis. 2014. PMID: 25369299 Review.

2

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. Ladeiro Y, et al. Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256. Hepatology. 2008. PMID: 18433021 Free article.

3

[miRNAs in cancer: the case of liver tumors].

Ladeiro Y, Zucman-Rossi J. Ladeiro Y, et al. Med Sci (Paris). 2009 May;25(5):467-72. doi: 10.1051/medsci/2009255467. Med Sci (Paris). 2009. PMID: 19480827 Free article. Review. French.

4

Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.

Imbeaud S, Ladeiro Y, Zucman-Rossi J. Imbeaud S, et al. Semin Liver Dis. 2010 Feb;30(1):75-86. doi: 10.1055/s-0030-1247134. Epub 2010 Feb 19. Semin Liver Dis. 2010. PMID: 20175035 Review.

5

Molecular classification of hepatocellular carcinoma.

Zucman-Rossi J. Zucman-Rossi J. Dig Liver Dis. 2010 Jul;42 Suppl 3:S235-41. doi: 10.1016/S1590-8658(10)60511-7. Dig Liver Dis. 2010. PMID: 20547309 Free article.

6

Genetics of hepatobiliary carcinogenesis.

Nault JC, Zucman-Rossi J. Nault JC, et al. Semin Liver Dis. 2011 May;31(2):173-87. doi: 10.1055/s-0031-1276646. Epub 2011 May 2. Semin Liver Dis. 2011. PMID: 21538283 Review.

7

Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma.

Llovet JM, Paradis V, Kudo M, Zucman-Rossi J. Llovet JM, et al. Liver Transpl. 2011 Oct;17 Suppl 2(Suppl 2):S67-71. doi: 10.1002/lt.22340. Liver Transpl. 2011. PMID: 21594967 Free PMC article. Review. No abstract available.

8

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.

Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, Poussin K, Zucman-Rossi J. Pilati C, et al. J Exp Med. 2011 Jul 4;208(7):1359-66. doi: 10.1084/jem.20110283. Epub 2011 Jun 20. J Exp Med. 2011. PMID: 21690253 Free PMC article.

9

GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.

Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, Tran Van Nhieu J, Saint-Paul MC, De Muret A, Redon MJ, Buffet C, Salenave S, Balabaud C, Prevot S, Labrune P, Bioulac-Sage P, Scoazec JY, Chanson P, Zucman-Rossi J. Nault JC, et al. J Hepatol. 2012 Jan;56(1):184-91. doi: 10.1016/j.jhep.2011.07.018. Epub 2011 Aug 9. J Hepatol. 2012. PMID: 21835143

10

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus Group. Clavien PA, et al. Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31. Lancet Oncol. 2012. PMID: 22047762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters